ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ジフェンヒドラミン 塩酸塩

Diphenhydramine Hydrochloride

HCID 8980
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
147-24-0
標準SMILES
CN(C)CCOC(c1ccccc1)c1ccccc1.Cl
InChIKey
PCHPORCSPXIHLZ-UHFFFAOYSA-N
分子式
C17H21NO.ClH
平均分子量
291.8 g/mol
単同位体質量
291.138992

概要

Diphenhydramine hydrochloride appears as white or almost-white crystalline powder. Odorless with a bitter numbing taste. pH (5% aqueous solution) 4-6. (NTP, 1992)

名称と識別子

優先名称
Diphenhydramine Hydrochloride
IUPAC
2-benzhydryloxy-N,N-dimethylethanamine;hydrochloride
現地名
ジフェンヒドラミン 塩酸塩
英語名
Diphenhydramine Hydrochloride
分子式
C17H22ClNO
分子量
291.82

名称と別名

DIPHENHYDRAMINE HYDROCHLORIDE147-24-0Diphenhydramine HClAllergivalBendylateAntitussiveDenydrylEldadrylFenylhistHydramineDibenilSilphen
名称をさらに表示
ジフェンヒドラミン 塩酸塩塩酸ジフェンヒドラミンジメドロールベナジフェンヒドラミン塩酸塩N,N-ジメチル-2-(ジフェニルメトキシ)エタンアミン·塩酸塩2-(α-フェニルベンジルオキシ)エチルジメチルアミン·塩酸塩レスタミン2-(ジフェニルメトキシ)-N,N-ジメチルエタンアミン·塩酸塩ベナスミンドリエルレスミンベナドリル2-ジフェニルメトキシ-N,N-ジメチルエタナミン塩酸塩2-(ベンズヒドリルオキシ)-N,N-ジメチルエチルアミン塩酸塩2-ジフェニルメトキシ-N,N-ジメチルエチルアミン塩酸塩ジフェンヒドラミンHCL2-(ジフェニルメトキシ)-N,N-ジメチルエチルアミン塩酸塩N,N-ジメチル-2-(ジフェニルメトキシ)エチルアミン塩酸塩ジフェンヒドラミン 塩酸塩BAXDiphenhydramine HCIBenylinBenacineAmbenylActifedDIMEDROLUMBENADRYL HCLcomponent of Caladryl
BeldinBelixDiphenDiphenhydramine.HClFelbenBenaDimedrol hydrochlorideHalbmond

データベース識別子

CAS
147-24-0
PubChem CID
8980
DTXSID
DTXSID4020537
ChEMBL
CHEMBL1620
UNII
TC2D6JAD40
EC Number
205-687-2

物性

構造計算による物性

極性表面積
12.5 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
6
重原子数
20
形式電荷
0
複雑度
211

実験および物理化学的性質

Chemical ClassesPharmaceutical
Solubility · 2 件

greater than or equal to 100 mg/mL at 70.7 °F (NTP, 1992)

>43.8 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Antihistamines

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point331 to 338 °F (NTP, 1992)
Physical DescriptionDiphenhydramine hydrochloride appears as white or almost-white crystalline powder. Odorless with a bitter numbing taste. pH (5% aqueous solution) 4-6. (NTP, 1992)
Collision Cross Section162.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
168 · 168-172 °C
沸点
163 · 163-167 °C(Press: 3 Torr)
比重(密度)
1.0489 · 1.0489 (rough estimate)
屈折率
1.58 · 1.5800 (estimate)
闪点
9 ℃ · 9℃
貯蔵温度
2 · 2-8°C
溶解性
水に非常に溶けやすく、アルコールに溶けやすい。
外見
結晶性粉末または付着結晶
色
白い
PH
pH(100g/L, 25℃) 4.0~5.5
水溶解度
1000 g/L · 1000g/L
Merck
14 · 14,3309
安定性
安定していますが、光の中でゆっくりと暗くなります。強力な酸化剤とは相容れない。
化粧品成分の機能
ヘアコンディショニングスキンコンディショニング
InChI
1S/C17H21NO.ClH/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;/h3-12,17H,13-14H2,1-2H3;1H
InChIKey
PCHPORCSPXIHLZ-UHFFFAOYSA-N
SMILES
Cl[H].CN(C)CCOC(c1ccccc1)c2ccccc2
LogP
3.662 · 3.662 (est)
CAS データベース
147 · 147-24-0(CAS DataBase Reference)
NISTの化学物質情報
diphenhydramine hydrochloride(147-24-0)
EPAの化学物質情報
Diphenhydramine hydrochloride (147-24-0)

化学的性質

化学的特性White or almost white, crystalline powder. odorless and has a bitter, numbing taste. soluble in water and in alcohol.

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Warning

H302 (99.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 221 reports by companies from 7 notifications to the ECHA C&L Inventory.

Danger

H302: Harmful if swallowed [Warning Acute toxicity, oral]

危険有害性情報

Regulatory InformationDiphenhydramine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride: Environment tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 件

SYMPTOMS: Symptoms of exposure to this compound may include photosensitivity, hypotension, headache, hemolytic anemia, dizziness, disturbed coordination, nervousness, tremor, insomnia, blurred vision, tinnitus, epigastric distress, nausea, vomiting, diarrhea, constipation and tightness of the chest. Other symptoms may include anaphylactic shock, fatigue, confusion, restlessness, euphoria, diplopia, urinary frequency, drowsiness, urticaria, drug rash, excessive perspiration, chills, dryness of the mouth, nose and throat, palpitations, tachycardia, extrasystoles, thrombocytopenia, agranulocytosis, sedation, excitation, irritability, paresthesia, acute labyrinthitis, neuritis convulsions, anorexia, difficult urination, urinary retention, early menses, thickening of bronchial secretions, wheezing and nasal stuffiness. Other symptoms may include inability to concentrate, muscular weakness, nightmares, difficulty in micturition, elation, depression, hyperpyrexia, muscle twitching lassitude, tingling, heaviness, and weakness of hands. Overdosage reactions may include atropine-like symptoms, dry mouth, fixed and dilated pupils, flushing, gastrointestinal symptoms, central nervous system depression to stimulation, hallucinations, convulsions and death.

Reactive GroupEthers
Reactivity ProfileDIPHENHYDRAMINE HYDROCHLORIDE gives acidic solutions in water. Neutralizes bases. May react with strong oxidizing and strong reducing agents. May catalyze organic reactions. Slowly darkens on exposure to light.
Air and Water ReactionsWater soluble. Aqueous solutions are acidic.
Hazard Classes and Categories · 2 件

Acute Tox. 4 (99.1%)

Acute toxicity (Oral) - Category 4

安全と保護具

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 件

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

毒性情報

Treatment · 1 件

There is no specific antidote for diphenhydramine toxicity, but the anticholinergic syndrome has been treated with physostigmine for severe delirium or tachycardia. Benzodiazepines may be administered to decrease the likelihood of psychosis, agitation, and seizures in patients who are prone to these symptoms.

Health EffectsThey cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive.
Exposure RoutesOral; topical ; parenteral(intramuscular or intravenous injection). Quickly absorbed with maximum activity occurring in approximately one hour.
Toxicity SummaryDiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.
Signs and SymptomsConsiderable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death.
Carcinogen Classification · 6 件

Diphenhydramine Hydrochloride

TR-355: Toxicology and Carcinogenesis Studies of Diphenhydramine Hydrochloride (CASRN 147-24-0) in F344/N Rats and B6C3F1 Mice (Feed Studies) (1989 )

10/03/88

Equivocal Evidence

Equivocal Evidence

No Evidence

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Diphenhydramine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 500 mg/kg (Oral, Rat) (A308)
USGS Health-Based Screening Levels for Evaluating Water-Quality · 3 件

Diphenhydramine

Pharmaceutical

Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP

安全データ

wgk
3
rtecs
KR7000000
ridadr
2811
毒性
LD50 orally in rats: 500 mg/kg (Gruhzit, Fisken)
hs_code
29221990
risk_code
22-39/23/24/25-23/24/25-11
化審法
(9)-484, (9)-690
hazard_code
Xn,T,F
safety_code
36-45-36/37-16-7-24/25
Hazard Classifications
Acute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Hepatic and renal Route of Elimination: Little, if any, is excreted unchanged in the urine; most appears as the degradation products of metabolic transformation in the liver, which are almost completely excreted within 24 hours. Half Life: 1-4 hours

FDA Pharmacological Classification · 6 件

ALLERGY DYEFREE

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

DIPHENHYDRAMINE HCI

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

DIPHENHYDRAMINE HCL

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 6 件

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Drugs used to prevent NAUSEA or VOMITING.

Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

用途と製造

UsesFor the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite.
応用分野 · 6 件

用途神経化学研究用。

用途ジフェンヒドラミン誘導体で す。抗ヒスタミン作用及びケミカルメディ エーター遊離抑制作用を示します。

用途抗アレルギー剤、抗ヒスタミン剤

説明Diphenhydramine is most commonly used as a first-generation antihistamine and is globally marketed in various brand formulations (Benadryl®, Unisom®, Tylenol®, Zzzquil®). It competitively blocks H1 receptors, thereby preventing the actions of histamine on bronchial smooth muscle, capillaries, and gastrointestinal (GI) smooth muscle. This prevents histamine-induced bronchoconstriction, vasodilation, increased capillary permeability, and GI smooth muscle spasms. Diphenhydramine exhibits anti-tussive, antiemetic, sedative, anti-allergic, and anticholinergic activities.

使用Diphenhydramine is a H1-histamine receptor antagonist with anticholinergic (drying) and sedative side effects. It is categorized as an antihistaminic; sedative, hypnotic, treatment of allergic. It is used to treat allergy and cold symptoms such as sneezing, runny nose, watery eyes, urticaria (hives), skin rash, and pruritus (itchy skin).

一般的な説明Diphenhydramine hydrochloride(Benadryl), is an oily, lipid-soluble free base available as the bitter-tasting hydrochloride salt, which is a stable, White or almost-white crystalline powder. Odorless with a bitter numbing taste. soluble in water (1:1), alcohol (1:2) and chloroform (1:2). The salt has a pKa value of 9, and a 1% aqueous solution has a pH of about 5.

調製方法 · 1 件

製造方法Diphenhydramine Hydrochloride synthesis is a four-step sequence starting with a Grignard reaction. Synthesis of Diphenhydramine Hydrochloride 6.A) modified synthetic route to diphenhydramine hydrochloride.B) Sequence of unit operations required for the synthesis. The dotted boxes denote the four stages of the synthesis. DMAE: dimethylaminoethanol.Organic synthesis in a modular robotic system driven by a chemical programming language

上流・下流製品情報

上流原料

炭酸ナトリウムジフェニルメタンジフェンヒドラミンエタノール塩酸

補足説明

定義本品は、ジフェニルメトキシジメチルエタノールアミンの塩酸塩であり、次の化学式で表される。

定義ChEBI: Diphenhydramine Hydrochloride is the hydrochloride salt form of diphenhydramine, an ethanolamine and first-generation histamine antagonist with anti-allergic activity.

関連反応

2 件
反応記録を作成
HRID 890919 の反応式
HRID 890919反応物として
HRID 2232939 の反応式
HRID 2232939反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート